Case Report

Pathological Approach to Genitourinary System Premalignant Lesions: Case Presentations from Clinical and Histological Perspectives

Volume: 11 Number: 4 November 30, 2025
Havva Erdem , Mürüvvet Akçay Çelik , Meltem Türk Alkan *, Beyza Bıyıklı , Büşra Erşan Erdem
PDF Download
Middle Black Sea Journal of Health Science Cover Middle Black Sea Journal of Health Science
EN

Pathological Approach to Genitourinary System Premalignant Lesions: Case Presentations from Clinical and Histological Perspectives

Abstract

Genitourinary system malignancies comprise a group of neoplasms that form the foundation of urological oncology and include some of the most common cancers in men. Within this group, prostate, bladder, kidney, and testicular cancers stand out due to their high incidence and varying characteristics in terms of histogenesis, molecular pathogenesis, and clinical behavior. In recent years, there has been growing interest in the identification and characterization of premalignant lesions, which are now recognized as histological precursors to invasive carcinomas. These lesions allow for early diagnosis and the development of targeted surveillance strategies. In this article, we present six cases diagnosed in our clinic, each representing a different type of premalignant lesion in the genitourinary system. The lesions include urothelial dysplasia, carcinoma in situ (CIS), keratinizing squamous metaplasia (KSM), and urothelial proliferation of unknown malignant potential (UPUMP) in the bladder; prostatic intraepithelial neoplasia (PIN), atypical small acinar proliferation (ASAP), and atypical adenomatous hyperplasia (AAH) in the prostate; and germ cell neoplasia in situ (GCNIS) in the testis. Premalignant lesions are histopathological changes that can be identified prior to the development of invasive malignancies, each carrying a different risk of progression. Accurate identification, knowledge of their morphological criteria, and support with immunohistochemical methods when necessary are critical in the diagnostic process. The cases presented in this study demonstrate the histopathological and clinical diversity of these lesions and offer guidance for diagnostic approaches. Early diagnosis of premalignant lesions in the genitourinary system is essential for preventing the development of invasive malignancies. Proper histopathological identification of these lesions enables appropriate clinical management and follow-up. The presented cases highlight the diagnostic features of various premalignant entities and emphasize the importance of multidisciplinary collaboration. Accurate recognition of these lesions by pathologists forms the cornerstone of early intervention and cancer prevention.

Keywords

Premalignant lesions , Genitourinary system , Dysplasia , Carcinoma in situ , Germ cell neoplasia in situ , Prostatic intraepithelial neoplasia

References

  1. Khani F, Robinson BD. Precursor Lesions of Urologic Malignancies. Arch Pathol Lab Med. 2017 Dec;141(12):1615-1632. doi: 10.5858/arpa.2016-0515-RA. Epub 2017 Aug 2. PMID: 28767283.
  2. Emerson RE, Cheng L. Premalignancy of the testis and paratestis. Pathology. 2013 Apr;45(3):264-72. doi: 10.1097/PAT.0b013e32835f3e1a. PMID: 23478232.
  3. Samaratunga H, Martignoni G, Egevad L, Delahunt B. Premalignant lesions of the urinary bladder. Pathology. 2013;45(3):243–250. doi:10.1097/PAT.0b013e32835f6169
  4. Athanazio DA, Trpkov K. What is new in genitourinary pathology? Appl Cancer Res. 2016;36(1). doi:10.1186/s41241-016-0003-7
  5. Chrisofos M, Papatsoris AG, Lazaris A, Deliveliotis C. Precursor lesions of prostate cancer. Crit Rev Clin Lab Sci. 2007;44(3):243–270. doi:10.1080/10408360601177236
  6. Amin MB, Trpkov K, Lopez-Beltran A, Grignon D, Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38(8):e20–e34. doi:10.1097/PAS.0000000000000240
  7. Anurag M, Strandgaard T, Kim SH, Dou Y, Comperat E, Al-Ahmadie H, et al. Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics. iScience. 2024;27(3):109179. doi:10.1016/j.isci.2024.109179
  8. Wolf H, Melsen F, Pedersen SE, Nielsen KT. Natural history of carcinoma in situ of the urinary bladder. Scand J Urol Nephrol Suppl. 1994; 157:147-51. PMID: 7939446.
  9. McKenney JK. Precursor lesions of the urinary bladder. Histopathology. 2019;74(1):68–76. doi:10.1111/his.13762
  10. Lowenthal BM, Sahoo D, Amin MB, Hansel DE. Urothelial Proliferation of Unknown Malignant Potential Involving the Bladder: Histopathologic Features and Risk of Progression in De Novo Cases and Cases With Prior Neoplasia. Arch Pathol Lab Med 1 July 2020; 144 (7): 853–862. doi: https://doi.org/10.5858/arpa.2019-0005-OA

Details

Primary Language

English

Subjects

Pathology

Journal Section

Case Report

Authors

Publication Date

November 30, 2025

Submission Date

July 18, 2025

Acceptance Date

October 17, 2025

Published in Issue

Year 2025 Volume: 11 Number: 4

DOI

https://doi.org/10.19127/mbsjohs.1745573

IZ

https://izlik.org/JA68ZR49CY

Cite

RIS / Bibtex
Vancouver
1.Havva Erdem, Mürüvvet Akçay Çelik, Meltem Türk Alkan, Beyza Bıyıklı, Büşra Erşan Erdem. Pathological Approach to Genitourinary System Premalignant Lesions: Case Presentations from Clinical and Histological Perspectives. Mid Blac Sea J Health Sci. 2025 Nov. 1;11(4):428-40. doi:10.19127/mbsjohs.1745573